Product catalog
contact us

    KCI BioTech (Suzhou) Inc.
    Tel:0512-69998806
    Ministry of Commerce:0512-69998806
    BD:
    North China:Mr. Xiong 15339988450
    East and South China:Ms. Gu 15378638068
    East China:Mr. Han 18914988667
    Central and Western regions: Ms. Xiang 15828112963
    Address: Building A2, Xinyang Industrial Park, No. 8 Yanghua Road, Suzhou Industrial Park

Key models for the development of atrial fibrillation drugs

Atrial fibrillation is a common rapid arrhythmia, occurring in 1% of people over the age of 60, and the incidence increases exponentially with age. The occurrence of atrial fibrillation is related to age and underlying disease type, and hypertension is the cardiovascular disease that is most prone to developing atrial fibrillation. Patients with concomitant atrial fibrillation have a significantly increased risk of developing embolic complications.

Our services

Model classification

Model Name

Animal species

Atrial fibrillation(AF)

Pacemaker-induced atrial fibrillation

Dog

Acetylcholine-induced atrial fibrillation

Dog

Case sharing

Pacemaker induced atrial fibrillation model in dogs

Previous:Myocarditis
Next:Ventricular tachycardia(VT)